Carlie LaLone
Adverse outcome pathway (AOP) development I: strategies and principles
DL Villeneuve, D Crump, N Garcia-Reyero, M Hecker, TH Hutchinson, ...
Toxicological Sciences 142 (2), 312-320, 2014
Adverse outcome pathway development II: best practices
DL Villeneuve, D Crump, N Garcia-Reyero, M Hecker, TH Hutchinson, ...
Toxicological Sciences 142 (2), 321-330, 2014
Editor’s highlight: sequence alignment to predict across species susceptibility (SeqAPASS): a web-based tool for addressing the challenges of cross-species extrapolation of …
CA LaLone, DL Villeneuve, D Lyons, HW Helgen, SL Robinson, ...
Toxicological Sciences 153 (2), 228-245, 2016
Effects of a glucocorticoid receptor agonist, dexamethasone, on fathead minnow reproduction, growth, and development
CA LaLone, DL Villeneuve, AW Olmstead, EK Medlock, MD Kahl, ...
Environmental Toxicology and Chemistry 31 (3), 611-622, 2012
Development of an adverse outcome pathway for acetylcholinesterase inhibition leading to acute mortality
CL Russom, CA LaLone, DL Villeneuve, GT Ankley
Environmental toxicology and chemistry 33 (10), 2157-2169, 2014
Molecular target sequence similarity as a basis for species extrapolation to assess the ecological risk of chemicals with known modes of action
CA LaLone, DL Villeneuve, LD Burgoon, CL Russom, HW Helgen, ...
Aquatic toxicology 144, 141-154, 2013
Current perspectives on the use of alternative species in human health and ecological hazard assessments
EJ Perkins, GT Ankley, KM Crofton, N Garcia-Reyero, CA LaLone, ...
Environmental health perspectives 121 (9), 1002-1010, 2013
The ECOTOXicology knowledgebase: A curated database of ecologically relevant toxicity tests to support environmental research and risk assessment
JH Olker, CM Elonen, A Pilli, A Anderson, B Kinziger, S Erickson, ...
Environmental Toxicology and Chemistry 41 (6), 1520-1539, 2022
Echinacea Species and Alkamides Inhibit Prostaglandin E2 Production in RAW264.7 Mouse Macrophage Cells
CA LaLone, KDP Hammer, L Wu, J Bae, N Leyva, Y Liu, AKS Solco, ...
Journal of agricultural and food chemistry 55 (18), 7314-7322, 2007
Echinacea in infection
DF Birt, MP Widrlechner, CA LaLone, L Wu, J Bae, AKS Solco, GA Kraus, ...
The American journal of clinical nutrition 87 (2), 488S-492S, 2008
Advancing the adverse outcome pathway framework—An international horizon scanning approach
CA LaLone, GT Ankley, SE Belanger, MR Embry, G Hodges, D Knapen, ...
Environmental toxicology and chemistry 36 (6), 1411-1421, 2017
Weight of evidence evaluation of a network of adverse outcome pathways linking activation of the nicotinic acetylcholine receptor in honey bees to colony death
CA LaLone, DL Villeneuve, J Wu-Smart, RY Milsk, K Sappington, ...
Science of the total environment 584, 751-775, 2017
Leveraging existing data for prioritization of the ecological risks of human and veterinary pharmaceuticals to aquatic organisms
CA LaLone, JP Berninger, DL Villeneuve, GT Ankley
Philosophical Transactions of the Royal Society B: Biological Sciences 369 …, 2014
Prioritization of pharmaceuticals for potential environmental hazard through leveraging a large‐scale mammalian pharmacological dataset
JP Berninger, CA LaLone, DL Villeneuve, GT Ankley
Environmental Toxicology and Chemistry 35 (4), 1007-1020, 2016
Evidence for cross species extrapolation of mammalian-based high-throughput screening assay results
CA LaLone, DL Villeneuve, JA Doering, BR Blackwell, TR Transue, ...
Environmental science & technology 52 (23), 13960-13971, 2018
Integrated assessment of runoff from livestock farming operations: Analytical chemistry, in vitro bioassays, and in vivo fish exposures
JE Cavallin, EJ Durhan, N Evans, KM Jensen, MD Kahl, DW Kolpin, ...
Environmental toxicology and chemistry 33 (8), 1849-1857, 2014
Nontarget screening of per-and polyfluoroalkyl substances binding to human liver fatty acid binding protein
D Yang, J Han, DR Hall, J Sun, J Fu, S Kutarna, KA Houck, CA LaLone, ...
Environmental science & technology 54 (9), 5676-5686, 2020
Cross‐species sensitivity to a novel androgen receptor agonist of potential environmental concern, spironolactone
CA LaLone, DL Villeneuve, JE Cavallin, MD Kahl, EJ Durhan, ...
Environmental toxicology and chemistry 32 (11), 2528-2541, 2013
Practical approaches to adverse outcome pathway development and weight‐of‐evidence evaluation as illustrated by ecotoxicological case studies
KA Fay, DL Villeneuve, CA LaLone, Y Song, KE Tollefsen, GT Ankley
Environmental Toxicology and Chemistry 36 (6), 1429-1449, 2017
Toxicology advances for 21st century chemical pollution
BW Brooks, T Sabo-Attwood, K Choi, S Kim, J Kostal, CA LaLone, ...
One Earth 2 (4), 312-316, 2020
Systém momentálně nemůže danou operaci provést. Zkuste to znovu později.
Články 1–20